title: [PATHOGENETIC TREATMENT OF CHRONIC NONBACTERIAL PROSTATITIS COMPLICATED BY SPERM DISORDERS].
abstract: This study examines the efficacy and safety of the natural complex of multi-component biologically active dietary supplement Prostatinol in the pathogenetic treatment of 45 patients with chronic nonbacterial Prostatitis complicated by sperm disorders. Within 4 weeks 25 patients of the treatment group and 20 patients of the control group received Prostatinol or traditional anti-inflammatory therapy correspondingly. The results were evaluated at weeks 4 and 12 after treatment cessation. Prostatinol was found to significantly increase the treatment effectiveness. More pronounced positive clinical effect was noted in 92% of treatment group patients receiving Prostatinol (disappearance of perineal pain, reduction of the IPSS score to an average of 2.1 points, absence of residual urine, normal Prostate echotexture, improvement of Prostate circulation, increase of sperm concentration and motility, higher pregnancy incidence among the wives of the treated patients). In the control group similar treatment effect was achieved in twice less number of patients. These results confirm that the components of the Prostatinol complex are effective, safe, have no side effects and can be used in the treatment of chronic Prostatitis, as well as for prevention of Prostatic diseases and improvement of sexual function.
authors.forename: S N
authors.initials: SN
authors.lastname: Kalinina
authors.forename: D G
authors.initials: DG
authors.lastname: Koren'kov
authors.forename: V N
authors.initials: VN
authors.lastname: Fesenko
authors.forename: D A
authors.initials: DA
authors.lastname: Demidov
authors.forename: N O
authors.initials: NO
authors.lastname: Tiktinskij
mesh_terms: D000328:Adult; D002908:Chronic Disease; D006801:Humans; D007248:Infertility, Male / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011247:Pregnancy; D011472:Prostatitis / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology